High Resolution Ultrasound in Pancreatic Ductal Adenocarcinoma

Advancing The Local Staging Of Pancreatic Ductal Adenocarcinoma Through High-Resolution Ultrasound: A Pilot Study

Status

Active, not recruiting

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03820661

Enrollment

Registered

2019-01-29

Start date

2019-02-01

Completion date

2026-12-31

Last updated

2024-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Ductal Adenocarcinoma

Brief summary

Pancreatic cancer patients at UHN who have had a CT at UHN and have surgery planned will undergo a high resolution ultrasound pre-operatively and intra-operatively. This study is being done to see if using high resolution ultrasound before and during surgery will help the doctors accurately diagnose pancreatic ductal adenocarcinoma and identify if the disease has spread to other areas of the body.

Interventions

DEVICEUltrasound

High resolution ultrasound pre-operatively and intra-operatively

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

1. Males and females \> 18 y 2. PDAC diagnosed by typical imaging findings or pathology 3. Scheduled for surgical resection 4. Contrast enhanced CT scan performed locally at UHN

Exclusion criteria

1\) Inability or unwillingness to provide informed consent

Design outcomes

Primary

Measure	Time frame	Description
High-resolution U/S will be used to measure vascular invasion and regional lymph node metastases in PDAC	within 2 weeks of surgery	The U/S results will be compared to pre-operative CT scan to help determine the diagnostic effectiveness of High Resolution US

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026